These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Residual neuromuscular blockade: management and impact on postoperative pulmonary outcome. Fuchs-Buder T; Nemes R; Schmartz D Curr Opin Anaesthesiol; 2016 Dec; 29(6):662-667. PubMed ID: 27755128 [TBL] [Abstract][Full Text] [Related]
23. Options on the use of muscle relaxants in clinical anaesthesia. Vilardi V Minerva Anestesiol; 2001 Mar; 67(3):91-5; discussion 95-6. PubMed ID: 11337640 [No Abstract] [Full Text] [Related]
24. Residual paralysis: a real problem or did we invent a new disease? Donati F Can J Anaesth; 2013 Jul; 60(7):714-29. PubMed ID: 23625545 [TBL] [Abstract][Full Text] [Related]
25. Neuromuscular transmission: new concepts and agents. de Boer HD J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537 [TBL] [Abstract][Full Text] [Related]
27. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia. Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656 [TBL] [Abstract][Full Text] [Related]
28. Sugammadex: a novel agent for the reversal of neuromuscular blockade. Nicholson WT; Sprung J; Jankowski CJ Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516 [TBL] [Abstract][Full Text] [Related]
29. Why are we using pulse oximetry but not neuromuscular monitoring routinely: the real world scenario? de Boer HD; Booij LH Anesth Analg; 2014 Mar; 118(3):690. PubMed ID: 24557114 [No Abstract] [Full Text] [Related]
30. [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks]. Unterbuchner C; Ehehalt K; Graf B Anaesthesist; 2019 Nov; 68(11):744-754. PubMed ID: 31650189 [TBL] [Abstract][Full Text] [Related]
31. [Residual neuromuscular blockade]. Beaussier M; Boughaba MA Ann Fr Anesth Reanim; 2005 Oct; 24(10):1266-74. PubMed ID: 16039822 [TBL] [Abstract][Full Text] [Related]
34. Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade. Fink H; Hollmann MW Minerva Anestesiol; 2012 Apr; 78(4):473-82. PubMed ID: 22454044 [TBL] [Abstract][Full Text] [Related]
35. [Prolonged residual paralysis after a single intubating dose of rocuronium: an unexpected cause]. Guerci P; Vial F; Raft J; Meistelman C; Bouaziz H Ann Fr Anesth Reanim; 2012; 31(7-8):632-4. PubMed ID: 22763308 [TBL] [Abstract][Full Text] [Related]
36. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study. Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924 [TBL] [Abstract][Full Text] [Related]
37. Evaluating a Quality Improvement Initiative to Increase Anesthesia Providers' Use of and Understanding of Quantitative Neuromuscular Monitors. Bedsworth MB; Harris EM; Vacchiano CA; Thompson JA; Grant SA; Goode VM AANA J; 2019 Oct; 87(5):357-363. PubMed ID: 31612840 [TBL] [Abstract][Full Text] [Related]